Literature DB >> 18853708

Clinical guideline for the evaluation and management of chronic insomnia in adults.

Sharon Schutte-Rodin1, Lauren Broch, Daniel Buysse, Cynthia Dorsey, Michael Sateia.   

Abstract

Insomnia is the most prevalent sleep disorder in the general population, and is commonly encountered in medical practices. Insomnia is defined as the subjective perception of difficulty with sleep initiation, duration, consolidation, or quality that occurs despite adequate opportunity for sleep, and that results in some form of daytime impairment.1 Insomnia may present with a variety of specific complaints and etiologies, making the evaluation and management of chronic insomnia demanding on a clinician's time. The purpose of this clinical guideline is to provide clinicians with a practical framework for the assessment and disease management of chronic adult insomnia, using existing evidence-based insomnia practice parameters where available, and consensus-based recommendations to bridge areas where such parameters do not exist. Unless otherwise stated, "insomnia" refers to chronic insomnia, which is present for at least a month, as opposed to acute or transient insomnia, which may last days to weeks.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18853708      PMCID: PMC2576317     

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN: 1550-9389            Impact factor:   4.062


  61 in total

1.  Characteristics of insomnia in the United States: results of the 1991 National Sleep Foundation Survey. I.

Authors:  S Ancoli-Israel; T Roth
Journal:  Sleep       Date:  1999-05-01       Impact factor: 5.849

Review 2.  Rules of evidence and clinical recommendations for the management of patients.

Authors:  D L Sackett
Journal:  Can J Cardiol       Date:  1993 Jul-Aug       Impact factor: 5.223

3.  Behavioral and pharmacological therapies for late-life insomnia: a randomized controlled trial.

Authors:  C M Morin; C Colecchi; J Stone; R Sood; D Brink
Journal:  JAMA       Date:  1999-03-17       Impact factor: 56.272

Review 4.  Derivation of research diagnostic criteria for insomnia: report of an American Academy of Sleep Medicine Work Group.

Authors:  Jack D Edinger; Michael H Bonnet; Richard R Bootzin; Karl Doghramji; Cynthia M Dorsey; Colin A Espie; Andrew O Jamieson; W Vaughn McCall; Charles M Morin; Edward J Stepanski
Journal:  Sleep       Date:  2004-12-15       Impact factor: 5.849

5.  Benzodiazepines and zolpidem for chronic insomnia: a meta-analysis of treatment efficacy.

Authors:  P D Nowell; S Mazumdar; D J Buysse; M A Dew; C F Reynolds; D J Kupfer
Journal:  JAMA       Date:  1997 Dec 24-31       Impact factor: 56.272

6.  Can we mix behavioral therapy with hypnotics when treating insomniacs?

Authors:  P J Hauri
Journal:  Sleep       Date:  1997-12       Impact factor: 5.849

Review 7.  Psychophysiological insomnia: the behavioural model and a neurocognitive perspective.

Authors:  M L Perlis; D E Giles; W B Mendelson; R R Bootzin; J K Wyatt
Journal:  J Sleep Res       Date:  1997-09       Impact factor: 3.981

Review 8.  Insomnia as a health risk factor.

Authors:  Daniel J Taylor; Kenneth L Lichstein; H Heith Durrence
Journal:  Behav Sleep Med       Date:  2003       Impact factor: 2.964

9.  Effects of exogenous melatonin on sleep: a meta-analysis.

Authors:  Amnon Brzezinski; Mark G Vangel; Richard J Wurtman; Gillian Norrie; Irina Zhdanova; Abraham Ben-Shushan; Ian Ford
Journal:  Sleep Med Rev       Date:  2005-02       Impact factor: 11.609

10.  Consulting about insomnia: a method and some preliminary data.

Authors:  P J Hauri
Journal:  Sleep       Date:  1993-06       Impact factor: 5.849

View more
  415 in total

1.  Melatonin.

Authors:  Michael D Carter; David N Juurlink
Journal:  CMAJ       Date:  2012-04-16       Impact factor: 8.262

2.  The anxious sleeper. Initiate sleep-restriction and stimulus-control techniques.

Authors:  Claudia M Toth
Journal:  J Clin Sleep Med       Date:  2010-08-15       Impact factor: 4.062

3.  Pharmacological Treatment of Insomnia.

Authors:  Janette D Lie; Kristie N Tu; Diana D Shen; Bonnie M Wong
Journal:  P T       Date:  2015-11

4.  Fiber and Saturated Fat Are Associated with Sleep Arousals and Slow Wave Sleep.

Authors:  Marie-Pierre St-Onge; Amy Roberts; Ari Shechter; Arindam Roy Choudhury
Journal:  J Clin Sleep Med       Date:  2016-01       Impact factor: 4.062

Review 5.  Sleep Disorders Among People With Schizophrenia: Emerging Research.

Authors:  Elizabeth A Klingaman; Jessica Palmer-Bacon; Melanie E Bennett; Laura M Rowland
Journal:  Curr Psychiatry Rep       Date:  2015-10       Impact factor: 5.285

Review 6.  Sublingual zolpidem (Edluar™; Sublinox™).

Authors:  Lily P H Yang; Emma D Deeks
Journal:  CNS Drugs       Date:  2012-11       Impact factor: 5.749

7.  Evaluating DSM-5 Insomnia Disorder and the Treatment of Sleep Problems in a Psychiatric Population.

Authors:  Lee Seng Esmond Seow; Swapna Kamal Verma; Yee Ming Mok; Sunita Kumar; Sherilyn Chang; Pratika Satghare; Aditi Hombali; Janhavi Vaingankar; Siow Ann Chong; Mythily Subramaniam
Journal:  J Clin Sleep Med       Date:  2018-02-15       Impact factor: 4.062

8.  Risk of psychiatric disorders in patients with chronic insomnia and sedative-hypnotic prescription: a nationwide population-based follow-up study.

Authors:  Kuo-Hsuan Chung; Chung-Yi Li; Shu-Yu Kuo; Trevor Sithole; Wen-Wei Liu; Min-Huey Chung
Journal:  J Clin Sleep Med       Date:  2015-04-15       Impact factor: 4.062

Review 9.  Treatment of Sleep Dysfunction in Parkinson's Disease.

Authors:  Amy W Amara; Lana M Chahine; Aleksandar Videnovic
Journal:  Curr Treat Options Neurol       Date:  2017-07       Impact factor: 3.598

10.  Eszopiclone treatment for insomnia: effect size comparisons in patients with primary insomnia and insomnia with medical and psychiatric comorbidity.

Authors:  Andrew D Krystal; W Vaughn McCall; Maurizio Fava; Hadine Joffe; Claudio N Soares; Holly Huang; Todd Grinell; Jacqueline Zummo; William Spalding; Randall Marshall
Journal:  Prim Care Companion CNS Disord       Date:  2012-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.